Skip to content
10-Q

Quarterly Report

GW PHARMACEUTICALS PLC

0001564590-20-038496

← back to feed
Filed
Aug 7, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 31, 2020 373.72M sh
Shares Diluted Q2 2020 · Jun 30, 2020 375.53M sh
Shares Diluted Q2 2020 · Jun 30, 2020 374.68M sh
Shares Diluted Q2 2020 · Jun 30, 2019 377.44M sh
Shares Diluted Q2 2020 · Jun 30, 2019 376.67M sh
Capex Q2 2020 · Jun 30, 2020 $11.36M
Capex Q2 2020 · Jun 30, 2019 $22.52M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$34.34M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$89.86M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $477.56M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $536.93M
Stockholders Equity Q2 2020 · Jun 30, 2020 $716.94M
Stockholders Equity Q2 2020 · Mar 31, 2020 $715.01M
Stockholders Equity Q2 2020 · Dec 31, 2019 $726.03M
Stockholders Equity Q2 2020 · Jun 30, 2019 $728.89M
Stockholders Equity Q2 2020 · Mar 31, 2019 $639.73M
Stockholders Equity Q2 2020 · Dec 31, 2018 $674.08M
Current Liabilities Q2 2020 · Jun 30, 2020 $118.5M
Current Liabilities Q2 2020 · Dec 31, 2019 $117.56M
Total Liabilities Q2 2020 · Jun 30, 2020 $153.64M
Total Liabilities Q2 2020 · Dec 31, 2019 $156.22M
Current Assets Q2 2020 · Jun 30, 2020 $687.72M
Current Assets Q2 2020 · Dec 31, 2019 $699.64M
Total Assets Q2 2020 · Jun 30, 2020 $870.58M
Total Assets Q2 2020 · Dec 31, 2019 $882.25M
Eps Diluted Q2 2020 · Jun 30, 2020 −$0.02
Eps Diluted Q2 2020 · Jun 30, 2020 −$0.04
Eps Diluted Q2 2020 · Jun 30, 2019 $0.21
Eps Diluted Q2 2020 · Jun 30, 2019 $0.08
Eps Basic Q2 2020 · Jun 30, 2020 −$0.02
Eps Basic Q2 2020 · Jun 30, 2020 −$0.04
Eps Basic Q2 2020 · Jun 30, 2019 $0.21
Eps Basic Q2 2020 · Jun 30, 2019 $0.08
Sga Expense Q2 2020 · Jun 30, 2020 $75.89M
Sga Expense Q2 2020 · Jun 30, 2020 $147.08M
Sga Expense Q2 2020 · Jun 30, 2019 $62.27M
Sga Expense Q2 2020 · Jun 30, 2019 $117.35M
Rd Expense Q2 2020 · Jun 30, 2020 $45.73M
Rd Expense Q2 2020 · Jun 30, 2020 $91.61M
Rd Expense Q2 2020 · Jun 30, 2019 $32.47M
Rd Expense Q2 2020 · Jun 30, 2019 $62.84M
Net Income Q2 2020 · Jun 30, 2020 −$8.83M
Net Income Q2 2020 · Jun 30, 2020 −$16.79M
Net Income Q2 2020 · Mar 31, 2020 −$7.97M
Net Income Q2 2020 · Jun 30, 2019 $79.75M
Net Income Q2 2020 · Jun 30, 2019 $29.68M
Net Income Q2 2020 · Mar 31, 2019 −$50.06M
Operating Income Q2 2020 · Jun 30, 2020 −$9.04M
Operating Income Q2 2020 · Jun 30, 2020 −$16.23M
Operating Income Q2 2020 · Jun 30, 2019 −$29.32M
Operating Income Q2 2020 · Jun 30, 2019 −$80.66M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $8.71M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $19.48M
Cost Of Revenue Q2 2020 · Jun 30, 2019 $6.62M
Cost Of Revenue Q2 2020 · Jun 30, 2019 $11.75M
Revenue Q2 2020 · Jun 30, 2020 $121.3M
Revenue Q2 2020 · Jun 30, 2020 $241.93M
Revenue Q2 2020 · Jun 30, 2019 $72.04M
Revenue Q2 2020 · Jun 30, 2019 $111.29M